Press Release | Tissuepathology.com

Aiforia won the Vuoden Digiteko 2026 (Digital Innovation of the Year) award – AI enhances cancer diagnostics

Erica Goodpaster — Fri, 09 Oct 2026 16:06:53 +0000

Aiforia Technologies Oyj, Press Release, October 9, 2026, at 8:00 a.m. EEST Aiforia, a developer of AI-powered solutions for cancer diagnostics, has won the prestigious “Vuoden Digiteko 2026” (Digital Innovation of the Year) public vote in the enterprise category. The “Vuoden Digiteko” competition rewards Finnish technology innovations and solutions that have an exceptionally high impact […]

The post Aiforia won the Vuoden Digiteko 2026 (Digital Innovation of the Year) award – AI enhances cancer diagnostics first appeared on Tissuepathology.com.

Aiforia collaborates with PathAI to broaden access to AI-driven diagnostics

Erica Goodpaster — Thu, 08 Oct 2026 12:49:23 +0000

Aiforia Technologies Plc, Press Release, October 8, 2026 at 09:00 a.m. EEST Aiforia, a pioneer in AI-driven diagnostics for pathology, today announced a commercial agreement with PathAI, a member of the Roche Group and a global leader in AI-powered digital pathology solutions and the developer of the market-leading AISight¹ Dx Image Management System (IMS). In […]

The post Aiforia collaborates with PathAI to broaden access to AI-driven diagnostics first appeared on Tissuepathology.com.

Tribun Health Expands into Australia as CaloPix(R) 6.2.0 Is Included in the ARTG

Erica Goodpaster — Wed, 07 Oct 2026 13:41:45 +0000

Trubun Health: Digital pathology platform registered for use in supporting primary diagnosis, opening a new market for Tribun Health and its partners PARIS, FR / ACCESS Newswire / October 6, 2026 / Tribun Health, a global provider of digital pathology solutions, today announced that CaloPix® 6.2.0 has been included in the Australian Register of Therapeutic […]

The post Tribun Health Expands into Australia as CaloPix(R) 6.2.0 Is Included in the ARTG first appeared on Tissuepathology.com.

Agendia to Showcase New Research on AI-Driven Digital Pathology at ESMO 2026

Erica Goodpaster — Tue, 06 Oct 2026 13:10:30 +0000

Agendia Podium presentation by Co-Founder and Chief Research Officer Laura van ’t Veer introduces an AI-driven approach to MammaPrint Two additional poster presentations from the FLEX Study IRVINE, Calif. & AMSTERDAM–(BUSINESS WIRE)–Agendia, Inc., a leader in precision oncology for breast cancer, announced today that it will present new research during a podium presentation on the […]

The post Agendia to Showcase New Research on AI-Driven Digital Pathology at ESMO 2026 first appeared on Tissuepathology.com.

Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region

Erica Goodpaster — Thu, 01 Oct 2026 12:27:10 +0000

Lunit: Following years of clinical validation and proven real-world performance at Saint Göran, Stockholm Region adopts Lunit INSIGHT MMG as an independent second reader at regional scale SEOUL, South Korea, Sept. 28, 2026 /PRNewswire/ — Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that its AI-powered mammography solution, […]

The post Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region first appeared on Tissuepathology.com.

ViewsML Appoints Digital Pathology Executive Michael Rivers to Board of Directors

Erica Goodpaster — Wed, 30 Sep 2026 12:10:25 +0000

Rivers brings more than 20 years of experience commercializing diagnostic and digital pathology technologies to support ViewsML’s continued growth and innovation Vancouver, BC —September 29, 2026— ViewsML, a leader in AI-powered virtual biomarker staining, today announced the appointment of Michael Rivers to its Board of Directors. Rivers brings more than 20 years of experience leading […]

The post ViewsML Appoints Digital Pathology Executive Michael Rivers to Board of Directors first appeared on Tissuepathology.com.